Medullary Thyroid Cancer - Feature Review and Update on Systemic Treatment.
RET proto-oncogene, molecular targeted therapy
medullary thyroid cancer
treatment
update
Journal
Acta clinica Croatica
ISSN: 1333-9451
Titre abrégé: Acta Clin Croat
Pays: Croatia
ID NLM: 9425483
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
entrez:
5
7
2021
pubmed:
6
7
2021
medline:
7
7
2021
Statut:
ppublish
Résumé
Medullary thyroid carcinoma (MTC) is a rare malignancy that originates from parafollicular (C cells) of the thyroid and accounts for 2-4% of all thyroid malignancies. MTC may be sporadic or inherited, the latter as part of the MEN 2 syndromes. Germline mutations in the
Identifiants
pubmed: 34219884
doi: 10.20471/acc.2020.59.s1.06
pii: acc-59-s1-50
pmc: PMC8212605
doi:
Substances chimiques
MAS1 protein, human
0
Proto-Oncogene Mas
0
Pyrazoles
0
Pyridines
0
selpercatinib
CEGM9YBNGD
Proto-Oncogene Proteins c-ret
EC 2.7.10.1
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
50-59Références
J Endocr Soc. 2018 Aug 13;2(10):1109-1130
pubmed: 30250937
Eur Thyroid J. 2013 Jan;1(4):216-31
pubmed: 24783025
Clin Endocrinol (Oxf). 1990 Aug;33(2):261-9
pubmed: 1977536
Endocr Rev. 2006 Aug;27(5):535-60
pubmed: 16849421
J Clin Endocrinol Metab. 2014 Dec;99(12):4390-6
pubmed: 25238206
Best Pract Res Clin Endocrinol Metab. 2017 Jun;31(3):335-347
pubmed: 28911729
Ann Oncol. 2019 Dec 1;30(12):1856-1883
pubmed: 31549998
Lancet Diabetes Endocrinol. 2016 Jan;4(1):64-71
pubmed: 26608066
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2004-2013
pubmed: 28646462
J Clin Endocrinol Metab. 2010 Jun;95(6):2655-63
pubmed: 20339026
Thyroid. 2008 Mar;18(3):317-23
pubmed: 17985985
Ann Oncol. 2017 Nov 1;28(11):2813-2819
pubmed: 29045520
Horm Metab Res. 2020 Aug;52(8):562-577
pubmed: 32040962
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Clin Endocrinol (Oxf). 2010 Apr;72(4):534-42
pubmed: 19563448
Expert Rev Anticancer Ther. 2018 Feb;18(2):149-159
pubmed: 29241377
J Clin Endocrinol Metab. 2014 May;99(5):1687-93
pubmed: 24606083
J Clin Endocrinol Metab. 2008 Mar;93(3):682-7
pubmed: 18073307
Hum Mutat. 2018 Jun;39(6):860-869
pubmed: 29656518
J Clin Endocrinol Metab. 2005 Nov;90(11):6077-84
pubmed: 16091497
Clin Endocrinol (Oxf). 2014 Jan;80(1):135-40
pubmed: 23627255
J Clin Oncol. 2012 Jan 10;30(2):134-41
pubmed: 22025146
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Mol Cancer. 2018 Feb 19;17(1):51
pubmed: 29455653
J Clin Oncol. 2010 May 10;28(14):2323-30
pubmed: 20368568
J Clin Oncol. 2013 Oct 10;31(29):3639-46
pubmed: 24002501
Cancer. 2014 Sep 1;120(17):2694-703
pubmed: 24844950
Cancer Discov. 2018 Jul;8(7):836-849
pubmed: 29657135
Nat Rev Endocrinol. 2016 Nov;12(11):646-653
pubmed: 27418023
Clin Nucl Med. 2015 Feb;40(2):123-7
pubmed: 25546220
Adv Ther. 2013 Nov;30(11):945-66
pubmed: 24249433
Eur J Cancer. 2017 May;77:140-152
pubmed: 28410490
Front Endocrinol (Lausanne). 2018 May 03;9:224
pubmed: 29774010
Eur Thyroid J. 2012 Apr;1(1):5-14
pubmed: 24782992
Best Pract Res Clin Endocrinol Metab. 2017 Jun;31(3):349-361
pubmed: 28911730
Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6696-702
pubmed: 18006770
Curr Opin Oncol. 2017 Jan;29(1):25-32
pubmed: 27792051
BMC Cancer. 2019 Apr 5;19(1):325
pubmed: 30953466
Endocr Relat Cancer. 2019 Aug 1;26(9):R499-R518
pubmed: 31252403
Rare Tumors. 2013 Jul 12;5(3):e37
pubmed: 24179649
Int J Mol Imaging. 2012;2012:324686
pubmed: 22852077
Semin Radiat Oncol. 2012 Jul;22(3):254-62
pubmed: 22687950
Thyroid. 2015 Jun;25(6):567-610
pubmed: 25810047
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3591-3599
pubmed: 28911154
J Clin Endocrinol Metab. 2012 Feb;97(2):426-35
pubmed: 22162466
Lancet Diabetes Endocrinol. 2019 Mar;7(3):213-220
pubmed: 30660595
Ann Oncol. 2018 Aug 1;29(8):1869-1876
pubmed: 29912274
JAMA Surg. 2018 Jan 1;153(1):52-59
pubmed: 28973144
J Clin Endocrinol Metab. 2006 Jul;91(7):2496-9
pubmed: 16608897
J Clin Endocrinol Metab. 2013 Feb;98(2):E364-9
pubmed: 23264394
Clin Cancer Res. 2016 Jan 1;22(1):44-53
pubmed: 26311725